MK-3475 Randomized, Phase II study of MK-3475 versus Chemotherapy

Printer-friendly versionSend by emailPDF version

Name

Merck and Company

Anticipated Amount

1 351 356.00

Activity Type

Clinical Trial

Award Type

Contract

Date

December 8, 2012 to August 29, 2014

Award Number

006135-00001

Sponsor Award Number

MK-3475-002-007

Award Contacts

Name

Cranmer,Lee D

Title

Principal Investigator

Unit

Cancer Center Division

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona